Joonghun Pharmaceutical

Joonghun Pharmaceutical is an active South Korean pharmaceutical company specializing in hyaluronic acid dermal fillers (notably 'Artgaon' and the 'Lorient' line), oral drugs, and COVID-19 diagnostic kits and treatments (including ribavirin). The company has developed a CE-marked portfolio of cross-linked hyaluronic acid dermal fillers, commercialized COVID-19 diagnostic kits and ribavirin for treatment, with products exported globally. Their portfolio spans aesthetics, orthopedics, and infectious diseases, operating with modalities including hyaluronic acid-based devices, diagnostic devices, biologics, and small molecules, and holding a notable international footprint.